Microstaging of pT1 transitional cell carcinoma of the bladder: Identification of subgroups with distinct risks of progression

Urology

Volumn 52, Issue 6, 1998, Pages 1009-1013

  Smits, Geert ^a   Schaafsma, Ewout ^a   Kiemeney, Lambertus ^a   Caris, Christien ^a   Debruyne, Frans ^a   Witjes, J Alfred ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER STAGING; FOLLOW UP; HUMAN; LAMINA PROPRIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TRANSITIONAL CELL CARCINOMA;

EID: 0032400794     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00374-4     Document Type: Article

References (20)

1. Heney N.M., Ahmed S., Flanagan M.J., et al. Superficial bladder cancer progression and recurrence . J Urol. 130:1983;1083-1086.
2. Kiemeney L.A.L.M., Witjes J.A., Heijbroek R.P., et al. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol. 150:1993;60-64.
3. Kurth K., Denis L., Sylvester R., et al. The natural history and the prognosis of treated superficial bladder cancer. Prog Clin Biol Res. 378:1992;1-7.
4. Catalona W.J., Dresner S.M., Haaff E.O. Management of superficial bladder cancer. Skinner D.G., Lieskovsky G. Diagnosis and Management of Genitourinary Cancer. 1988;281-294 Alan R. Liss, New York.
5. Vet J.A.M., Debruyne F.M.J., Schalken J.A. Molecular prognostic factors in bladder cancer. World J Urol. 12:1994;84-89.
6. Theodoresku D. Commentary on genetic prognostic markers for transitional cell carcinoma of the bladder from microscopes to molecules . J Urol. 155:1996;2.
7. Younes M., Sussman J., True L.D. The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder. Cancer. 66:1990;543-548.
8. Hasui Y., Osada Y., Kitada S., et al. Significance of invasion to the muscularis mucosa on the progression of superficial bladder cancer. Urology. 43:1994;782-786.
9. Angulo J.C., Lopez J.I., Grignon D.J., et al. Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer. Urology. 45:1995;47-53.
10. Holmäng S., Hedelin H., Anderström C., et al. The importance of the depth of invasion in stage T1 bladder carcinoma a prospective cohort study . J Urol. 157:1997;800-804.
11. Murphy W.M. Editorial comment on depth of invasion in stage T1 bladder cancer. J Urol. 157:1997;804.
12. Platz C.E., Cohen M.B., Jones M.P., et al. Is microstaging of early invasive cancer of the urinary bladder possible or useful? Mod Pathol. 9:1996;1035-1039.
13. Witjes J.A., van der Meyden A.P.M., Witjes W.P.J., et al. A randomized prospective study comparing intravesical installations of mitomycin-C, bacillus Calmette-Guérin Tice and bacillus Calmette-Guérin RIVM in pTa-pT1 tumors and carcinoma in situ of the urinary bladder. Eur J Cancer. 29a:1993;1672-1676.
14. Vegt P.D.J., Witjes J.A., Witjes W.P.J., et al. A randomized study of intravesical mitomycin-C, bacillus Calmette-Guérin Tice and bacillus Calmette-Guérin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder. J Urol. 153:1995;929-933.
15. Mostofi F.K., Sobin L.H., Torloni H. Histological Typing of Urinary Bladder Tumours. International Histological Classification of Tumours, No. 10. 1973;World Health Organization, Geneva.
16. Pauwels R.P.E., Schapers R.F.M., Smeets A.W.G.B., et al. Grading in superficial bladder cancer. 1. Morphological criteria. Br J Urol. 61:1988;129-134.
17. Carbin B.E., Ekman P., Gustafson H., et al. Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency histologic description . J Urol. 145:1991;968-997.
18. Cox D.R. Regression models and life-tables. J R Stat Soc. 34:1992;187.
19. Witjes J.A., Kiemeney L.A.L.M., Schaafsma H.E., et al. The influence of review pathology on study outcome of a randomised multicentre superficial bladder cancer trial. Br J Urol. 73:1994;172-176.
20. Kiemeney L.A.L.M., Verbeek A.L.M., van Houwelingen J.C. Prognostic assessment from non-randomized treatment assignment. J Clin Epidemiol. 47:1994;241-247.